ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

Columnist Mary Shaniqua offers examples of some symptoms of sickle cell that are lesser known than fatigue and a ...

Harrisburg lost a healthcare titan to a disease she fought her entire life to treat. Dr. Gwendolyn Poles-Corker, died April 8 at the age of 71 from complications of sickle cell disease. Her funeral is ...

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

CASGEVY became the world's first genome editing therapy to receive marketing authorization, beginning with the United Kingdom ...

Sickle Cell Disease is a genetic blood disorder characterised by the presence of sickle-shaped red blood cells, which can block blood flow, cause chronic pain, and lead to a host of physical ...

Reshma Kewalramani is the only person of Indian-origin to find her way to the 2025 list. Kewalramani emigrated to the United ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The ...

A federal district court had ruled in favor of HHS, restricting Vertex's ability to provide fertility preservation services to Medicaid patients.

The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and other publications ...

Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On ...

Reshma Kewalramani, CEO of Vertex Pharmaceuticals, is honored as one of Time's 100 most influential people of 2025. Under her ...